Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Recipharm to buy Sanofi's inhalation businesses in U.K. for GBP 45m
June 15, 2018

Recipharm has struck a deal with Sanofi to buy the French drugmaker’s contract inhalation drug business and plant in the U.K., picking up new capabilities and clients in the process. Sanofi makes metered-dose inhalers and nasal sprays for contract clients. The deal is scheduled to close in the fourth quarter of 2018, at which point Recipharm will add the plant’s 450 employees.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: